Načítá se...

Androgen Receptor-Dependent and -Independent Mechanisms Involved in Prostate Cancer Therapy Resistance

Despite the initial efficacy of androgen deprivation in prostate cancer, virtually all patients progress to castration-resistant prostate cancer (CRPC). Androgen receptor (AR) signaling is critically required for CRPC. A new generation of medications targeting AR, such as abiraterone and enzalutamid...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancers (Basel)
Hlavní autoři: Crona, Daniel J., Whang, Young E.
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2017
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5483886/
https://ncbi.nlm.nih.gov/pubmed/28604629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers9060067
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!